NEW YORK (GenomeWeb) – Guardant Health and OncoMed Pharmaceuticals said today that they would collaborate on an immunoncology clinical trial. The companies have developed a custom-designed blood test based on Guardant Health's liquid biopsy technology to look for biomarkers relevant for an anti-RSP03 antibody OncoMed has developed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.

Jun
29
Sponsored by
PerkinElmer

This online seminar will provide an overview of current standardization efforts in genomics, epigenomics, and metagenomics, with a focus on practical implementation considerations for researchers and labs.

Jul
20
Sponsored by
NuGEN

This webinar describes the characterization of gene fusions across distinct subtypes of melanoma.